Anticholinergic

16 marketed 4 in Phase 3 6 in Phase 2

This page covers all Anticholinergic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M3, 5-hydroxytryptamine receptor 2A, Cytochrome P450 2D6, D(2) dopamine receptor.

Targets

Muscarinic acetylcholine receptor M4 · Muscarinic acetylcholine receptor M3 · 5-hydroxytryptamine receptor 2A, Cytochrome P450 2D6, D(2) dopamine receptor · Muscarinic acetylcholine receptor M1 · Muscarinic acetylcholine receptor M2 · Muscarinic acetylcholine receptors (M2 and M3) · Histamine H2 receptor · M3 receptors, beta 2 -adrenergic receptors · M1 muscarinic receptor · Muscarinic acetylcholine receptor

Marketed (16)

Phase 3 pipeline (4)

Phase 2 pipeline (6)